Clorox anticipates a difficult fiscal year, citing persistent inflation and consumers prioritizing value. The company projects sales to increase between 13% and 14%, largely driven by its acquisition of Gojo, the maker of Purell. Adjusted earnings per share are expected to range from $5.70 to $6.00.

This forecast falls within analyst expectations, who had predicted adjusted earnings of $5.93 and sales growth of approximately 13.5%. Despite these projections, Chief Executive Linda Rendle acknowledged the ongoing challenges.

"We expect the operating environment to remain challenging, with continued cost volatility and a value-seeking consumer," Rendle stated. The company's cost-saving measures are expected to be outpaced by inflationary pressures and shifts in consumer spending habits.